Richard Jon Davis
11Patents
4h-index
14Co-inventors
49Inventor score
Filing activity: Jul 3, 2001 → Jan 28, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7326732B2 | EP2 receptor agonists | Chemistry; Metallurgy | 9 | Expired |
| US7803841B2 | EP2 receptor agonists | Chemistry; Metallurgy | 6 | Active |
| US7417068B2 | EP4 receptor antagonists | Human Necessities | 5 | Expired |
| US7196089B2 | EP4 receptor antagonists | Chemistry; Metallurgy | 5 | Expired |
| US7569602B2 | Furan derivatives as EP4 receptor antagonists | Human Necessities | 4 | Expired |
| US8080567B2 | EP2 receptor agonists | Chemistry; Metallurgy | 2 | Active |
| US7662839B2 | EP2 receptor agonists | Chemistry; Metallurgy | 2 | Active |
| US7507754B2 | EP4 receptor antagonists | Chemistry; Metallurgy | 2 | Active |
| US7528157B2 | EP4 receptor antagonists | Chemistry; Metallurgy | 2 | Active |
| US7858644B2 | EP4 receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US6780839B2 | Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.